1a/jamanetwork.com/journals/jama/… Interesting paper recently pub by JAMA. re: prior C19 in mRNA vaxed persons. This D/N compare V+PI vs. PI alone, but V+PI vs. Vax alone (a different ?). PI + Vax significantly reduced infection risk compared to mRNA Vax alone. Fascinating result in🧵👇
1b/ SPOILER: Vaxed persons with a PI had a much lower rate of infection, in both Pfizer (0.18x) and Mdrna (0.35x). But MORE INTERESTING: Those Vaxed >6m after PI did better than Vax<6 months, by a lot!
(fyi, PI= prev. inf, nPI= not PI).
2/ Some may misinterpret the meaning of the study here. So to be clear: THIS DOES NOT ANSWER the ?? of whether vax significantly reduces infection risk in PI persons. Instead, it asks the converse: does PI reduce risk in vaxed persons?
3/ The study draws from a national Qatari database, of more than 1.5M persons who were vaccinated between 12/20 and 9/21, with follow-up starting 14 days after 2nd dose. They used a “matched cohort” design.
4a/ Briefly, for study looked at Pfizer and Moderna vaccinees separately. Authors matched all PI persons within each group 3:1 with nPI persons, according to age, sex, nationality, and vax dose month. Then looked at infection rates.
4b) The methodology looks sound, and the matching process appears to have been done properly, minimizing noisy adjustments.
5/ The results demonstrated significant risk reduction for vaccinees in PI. Adjusted HR (aHRs) below:
Pfizer: 0.18 (Vax/PI << Vax/nPI)
Mdrna: 0.35 (Vax/PI <<Vax/nPI)
KM Curves below:
6/ Additionally, authors note aHRs decreasing by month, suggesting accelerated vax waning in nPI>PI persons with time. This effect was more dramatic with Moderna vaccine. PI persons appeared protected from vax waning.
7/ Perhaps, most interestingly – authors also looked at timing of vax after PI, on infection rate. And they found: Vax >6 months after PI had significantly LOWER re-infection rates then Vax<6mos. aHRs:
Pfizer: 0.62
Moderna: 0.40
(!!!)
8/ The authors d/n postulate reasons for this result, but it implies that those with longer PI-vax interval have BETTER post-vax protection. Could earlier vax after PI impair natural immunity process, or later vax more effective? Both possibilities must be strongly considered!
9/ BUT, the question to VAX is still up in the AIR. Because, in this study, we do not know what the rate of reinfection is prior to Vax, and the length of time a pre-vaxed PI person may be at elevated risk reinfection risk.
10/ Based on this study, however, the marginal risk a PI person takes in waiting to get vax, may be countered by the additional protection gained by waiting to get vax. If a PI person gets vaxed, TIMING IS IMPORTANT.
11a/ And of course, study limitations are important. PI was determined by PCR, so asymptomatics could be misclassified. Also PI persons may “select” for healthier persons due to mortality (which was very low in Qatar).
11b/ Also Qatar is a very young population, and its demographics may not be particularly generalizable to other national populations.
12/ HOWEVER, our current policies (wrongly) do not consider PI at all, let alone timing after PI. This study suggests that there may be trade-offs between early and late vax after PI, and maybe an optimal “window”.
13a/ Moreover, there may be millions of people who have had asymptomatic infections, and seroconverted recently and quietly. If this study is true, rush to vax without knowing “immune” status may mute level of protection!
13b/ Its complicated! The proper time for vaccination in PI persons (if any) should be determined by person, their physician, and relevant immunological testing. Not MANDATES!
14/ MANDATES are inefficient. In scenarios where the risk-benefit calculations can become complex, persons are forced into vax only for socioeconomic reasons – not clinically optimal reasons. This is particularly true in the previously infected and 5-11yos.
15/ Knowing this will fall on deaf ears, I still call on the CDC to consider more nuance in their vaccination guidance for PI persons. Health and professional livelihoods depend on it !!!

Thank you for reading. As always, open to discussion comments/corrections/concerns.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Mahesh Shenai, MD

Mahesh Shenai, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @mahesh_shenai

1 Nov
1/ cdc.gov/coronavirus/20… After release of their MMWR study, CDC releases this BRIEF on Infection-induced vs. Vax-induced Immunity. It is a CONFUSED document – both accepting NI, but illogically recommending VAX anyway. This 🧵🧵 appraises the BRIEF –
2a/ It is important that the CDC get this STRAIGHT. For children 5-11 particularly, NI reduces C19 risk significantly, to the point that the vaccine offers virtually no benefit to COVID-recovered children. The ACIP meets tomorrow on this question. They NEED to address NI (PI)!
2b/ We will go through the document section by section, highlighting key takeaways and provide refutations/commentary if necessary.
Read 41 tweets
31 Oct
1/ 🚨🚨 cdc.gov/mmwr/volumes/7… This MMWR article is a confluence of methodological flaws, that amplify to serve the predetermined message of the CDC. This 🧵 will summarize my appraisals.
2a/ On a high-level, they utilize “adjusted” odds ratios to dramatize the result. The ACTUAL raw difference between PI and Vax is actually small: 8.7% PI vs. 5.1% Vax in HOSPITALIZED PATIENTS with C19-like symptoms. 3.6%. That is a SMALL difference in a very SPECIFIC population.
2b/ On ABSOLUTE TERMS this is rather small, and can easily created by subtle selection bias. If they could find 53 fewer PI infxns or 228 vax infxms out of 201, 000 eligible patients --- the ORs would “break even”.
Read 37 tweets
29 Oct
1/ IMPORTANT THREAD: @ 5-11 VRBPAC Members saw “scenario analysis” of vax BENEFIT vs RISK, by an FDA epidemiologist. The math is simple, but the scenarios considered were FLAWED & NARROW. This 🧵recreates the model w/ new and more germane scenarios.
1b/ SPOILERS FIRST:
In AVERAGE INCIDENCE SCENARIOS , vax prevents CASES in COVID-(N)aive on par with vax “related AEs”, AND serious AEs/death generally on par w/ C19 hosps saved.
1c/ For COVID-(R)ecovered, all AEs gneerally exceed C19 cases/hosp/death prevented, in all but most extreme assumptions (occurring ALL AT THE SAME TIME, sustained throughout the entire period).
Read 35 tweets
26 Oct
fda.gov/media/153507/d…
1/ Interesting risk-benefit analysis for 5-11yos from Dr.Yang, an FDA epidemiologist, providing scenarios at VRBPAC (not Pfizer sponsored analysis). It favors the OPTION for vaccine, but argues against any MANDATE. This🧵interprets this presentation.
2/ Analysis calculates the number of Cases, Hospitalizations, ICU stays, and Deaths prevented by vax, compared to the excess of same complications by myocarditis/pericarditis. Myo/pericarditis is the only complication considered.
3/ They tested several scenarios with peak incidences (recent Delta phase), vs. baseline incidences. They also tested for assumptions on various VE and rates of vax-induced myocarditis, broken down by M/F.
Read 17 tweets
18 Oct
1/ As the @FDA decides on EUA for 5-11 yos, w/ minimal efficacy data, the most NEGLECTED subgroup are COVID-recovered 5-11yos, who have virtually no representation in any study. This THREAD attempts to quantify the benefit of vaccination in this subgroup. @noorchashm @ToddZywicki
2/ Recovered 5-11 yos have 3 coinciding reasons for minimal benefit from vax: 1) extremely low rates of symptom. morbidity, 2) adult data suggesting notable protection (70-90%) from NI alone, 3) adult data suggesting vax in recovered is 18-33%. Let us examine each: @JeanRees10
3a/ 1st, from CDC data below – 5-11yos (exclusively unvaxed) currently one of the highest inc, of infxn (currently near peak at 218/100k-wk). Deaths are virtually immeasurable. This is near the peak of the most recent wave. On average throughout pandemic , it is much lower.
Read 19 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(